Literature DB >> 8257637

The effect of age on the course of experimental feline immunodeficiency virus infection in cats.

J W George1, N C Pedersen, J Higgins.   

Abstract

Neonatal, young adult, and aged specific pathogen-free cats were experimentally infected with cat-passaged Petaluma strain of feline immunodeficiency virus. The primary stage of illness occurred 6-8 weeks following infection in cats of all ages, but it differed in severity and clinical signs. Generalized lymphadenopathy persisted for the entire 42-week study period in neonatally infected cats, was transient in young adults, but inapparent in aged cats. Only two aged cats became chronically and severely ill during the study. One aged cat died with severe necrotizing transmural enteritis, while a second developed chronic generalized staphylococcal pyoderma that was partially controlled with antibiotics. Neutropenia appeared 6-8 weeks following infection in cats of all ages, but was more severe in newborn and aged cats than in young adults. A persistent decrease in CD4+/CD8+ T lymphocyte ratios, due to both increased CD8+ and decreased CD4+ T lymphocytes, occurred in the neonatal and aged cats. Decreased CD4+/CD8+ T lymphocyte ratios in the young adult cats was due solely to decreased CD4+ T lymphocytes. Antibody response to FIV virus, as measured by ELISA to recombinant FIV p24 antigen, was lower in aged cats than the other age groups during the first 6 weeks after infection. Antibody levels were not significantly different among the three age groups thereafter. Although there are some differences between FIV infection of cats and HIV infection of human beings, age at infection influences the severity of disease in both species.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8257637     DOI: 10.1089/aid.1993.9.897

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  12 in total

1.  Differential cell tropism of feline immunodeficiency virus molecular clones in vivo.

Authors:  G A Dean; S Himathongkham; E E Sparger
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

Review 2.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

3.  Plasma viral RNA load predicts disease progression in accelerated feline immunodeficiency virus infection.

Authors:  L J Diehl; C K Mathiason-Dubard; L L O'Neil; E A Hoover
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

Review 4.  Immunopathogenesis of feline immunodeficiency virus infection in the fetal and neonatal cat.

Authors:  Holly M Kolenda-Roberts; Leah A Kuhnt; Ryan N Jennings; Ayalew Mergia; Nazareth Gengozian; Calvin M Johnson
Journal:  Front Biosci       Date:  2007-05-01

5.  Neurovirulence in feline immunodeficiency virus-infected neonatal cats is viral strain specific and dependent on systemic immune suppression.

Authors:  C Power; R Buist; J B Johnston; M R Del Bigio; W Ni; M R Dawood; J Peeling
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

6.  Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-alpha plasmids preserves global CD4 T lymphocyte function after challenge with FIV.

Authors:  Saipiroon Maksaereekul; Robert A Dubie; Xiaoying Shen; Hung Kieu; Gregg A Dean; Ellen E Sparger
Journal:  Vaccine       Date:  2009-04-17       Impact factor: 3.641

7.  Contrasting clinical outcomes in two cohorts of cats naturally infected with feline immunodeficiency virus (FIV).

Authors:  Paweł M Bęczkowski; Annette Litster; Tsang Long Lin; Dominic J Mellor; Brian J Willett; Margaret J Hosie
Journal:  Vet Microbiol       Date:  2015-01-03       Impact factor: 3.293

Review 8.  Feline immunodeficiency virus infection: an overview.

Authors:  K Hartmann
Journal:  Vet J       Date:  1998-03       Impact factor: 2.688

9.  A novel method for producing target cells and assessing cytotoxic T lymphocyte activity in outbred hosts.

Authors:  Francesca Bonci; Elisa Zabogli; Francesca Conti; Antonio Merico; Giulia Freer; Mauro Bendinelli; Mauro Pistello
Journal:  BMC Biotechnol       Date:  2009-03-11       Impact factor: 2.563

Review 10.  Haematological disorders associated with feline retrovirus infections.

Authors:  M L Linenberger; J L Abkowitz
Journal:  Baillieres Clin Haematol       Date:  1995-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.